explore -WSS

explore

author：focus 2025-08-26 10:55:48 - browse：778

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： ACA's risk program benefits Blue Cross Blue Shield insurers

WSS

The U.S. needs a new definition of substance use “recovery”

Pandemic and All Hazards Preparedness Act needs lean update

Celiac disease study examines precisely how gluten triggers injury

Care demand spikes challenge UnitedHealth’s provider arm

Celiac disease study examines precisely how gluten triggers injury

Eli Lilly to acquire Versanis in heated race for weight loss drugs

hotspot

explore

hotspot

Heart attack and stroke risk calculators need revising

Blood tests recalled over risk of missed heart attack diagnosis

Psychedelics group wrestles with new pharma identity

Recent heat wave in the Mediterranean caused by climate change: Study

Guidelines to prevent youth baseball injuries need more muscle

Medicare wants to send $9 billion to 340B hospitals

As demand for Covid shots wanes, Moderna seeks its next success

Teachers share how revamped forgiveness program helped with their student loans

How to save PrEP access — and even expand it

Pandemic and All Hazards Preparedness Act needs lean update

explore

Why police arrested suspected Gilgo Beach killer away from his house

Biden declares emergency in flood

White House announces new plan to address the growing threat of xylazine in overdose crisis

Argenx drug significantly slows progression of nerve disorder

Biden targets hefty hospital 'facility fees' that often surprise patients

Presidential fundraising highlights so far: Trump brings in more than DeSantis

hotspot

Wikipedia

knowledge

focus